Qiagen NV | QIA - Current Assets

Stock Price
43.87
Daily Change
-0.17 -0.37%
Monthly
12.86%
Yearly
4.71%
Q1 Forecast
43.53

Qiagen NV reported $2.53B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
argenx SE USD 5.83B 946.64M Jun/2025
Avita Medical AUD 36.25M 20.75M Jun/2025
Dianthus Therapeutics USD 413.82M 150.22M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
Moderna USD 6.6B 427M Sep/2025
Organon & Co USD 4.7B 82M Sep/2025
Qiagen NV USD 2.53B 711.95M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Viatris USD 9.95B 176.8M Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025